FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380768002> ?p ?o ?g. }

• W4380768002 abstract "Abstract STUDY QUESTION How should recurrent implantation failure (RIF) in patients undergoing ART be defined and managed? SUMMARY ANSWER This is the first ESHRE good practice recommendations paper providing a definition for RIF together with recommendations on how to investigate causes and contributing factors, and how to improve the chances of a pregnancy. WHAT IS KNOWN ALREADY RIF is a challenge in the ART clinic, with a multitude of investigations and interventions offered and applied in clinical practice, often without biological rationale or with unequivocal evidence of benefit. STUDY DESIGN, SIZE, DURATION This document was developed according to a predefined methodology for ESHRE good practice recommendations. Recommendations are supported by data from the literature, if available, and the results of a previously published survey on clinical practice in RIF and the expertise of the working group. A literature search was performed in PubMed and Cochrane focussing on ‘recurrent reproductive failure’, ‘recurrent implantation failure’, and ‘repeated implantation failure’. PARTICIPANTS/MATERIALS, SETTING, METHODS The ESHRE Working Group on Recurrent Implantation Failure included eight members representing the ESHRE Special Interest Groups for Implantation and Early Pregnancy, Reproductive Endocrinology, and Embryology, with an independent chair and an expert in statistics. The recommendations for clinical practice were formulated based on the expert opinion of the working group, while taking into consideration the published data and results of the survey on uptake in clinical practice. The draft document was then open to ESHRE members for online peer review and was revised in light of the comments received. MAIN RESULTS AND THE ROLE OF CHANCE The working group recommends considering RIF as a secondary phenomenon of ART, as it can only be observed in patients undergoing IVF, and that the following description of RIF be adopted: ‘RIF describes the scenario in which the transfer of embryos considered to be viable has failed to result in a positive pregnancy test sufficiently often in a specific patient to warrant consideration of further investigations and/or interventions'. It was agreed that the recommended threshold for the cumulative predicted chance of implantation to identify RIF for the purposes of initiating further investigation is 60%. When a couple have not had a successful implantation by a certain number of embryo transfers and the cumulative predicted chance of implantation associated with that number is greater than 60%, then they should be counselled on further investigation and/or treatment options. This term defines clinical RIF for which further actions should be considered. Nineteen recommendations were formulated on investigations when RIF is suspected, and 13 on interventions. Recommendations were colour-coded based on whether the investigations/interventions were recommended (green), to be considered (orange), or not recommended, i.e. not to be offered routinely (red). LIMITATIONS, REASONS FOR CAUTION While awaiting the results of further studies and trials, the ESHRE Working Group on Recurrent Implantation Failure recommends identifying RIF based on the chance of successful implantation for the individual patient or couple and to restrict investigations and treatments to those supported by a clear rationale and data indicating their likely benefit. WIDER IMPLICATIONS OF THE FINDINGS This article provides not only good practice advice but also highlights the investigations and interventions that need further research. This research, when well-conducted, will be key to making progress in the clinical management of RIF. STUDY FUNDING/COMPETING INTEREST(S) The meetings and technical support for this project were funded by ESHRE. N.M. declared consulting fees from ArtPRED (The Netherlands) and Freya Biosciences (Denmark); Honoraria for lectures from Gedeon Richter, Merck, Abbott, and IBSA; being co-founder of Verso Biosense. He is Co-Chief Editor of Reproductive Biomedicine Online (RBMO). D.C. declared being an Associate Editor of Human Reproduction Update, and declared honoraria for lectures from Merck, Organon, IBSA, and Fairtility; support for attending meetings from Cooper Surgical, Fujifilm Irvine Scientific. G.G. declared that he or his institution received financial or non-financial support for research, lectures, workshops, advisory roles, or travelling from Ferring, Merck, Gedeon-Richter, PregLem, Abbott, Vifor, Organon, MSD, Coopersurgical, ObsEVA, and ReprodWissen. He is an Editor of the journals Archives of Obstetrics and Gynecology and Reproductive Biomedicine Online, and Editor in Chief of Journal Gynäkologische Endokrinologie. He is involved in guideline developments and quality control on national and international level. G.L. declared he or his institution received honoraria for lectures from Merck, Ferring, Vianex/Organon, and MSD. He is an Associate Editor of Human Reproduction Update, immediate past Coordinator of Special Interest Group for Reproductive Endocrinology of ESHRE and has been involved in Guideline Development Groups of ESHRE and national fertility authorities. D.J.M. declared being an Associate Editor for Human Reproduction Open and statistical Advisor for Reproductive Biomedicine Online. B.T. declared being shareholder of Reprognostics and she or her institution received financial or non-financial support for research, clinical trials, lectures, workshops, advisory roles or travelling from support for attending meetings from Ferring, MSD, Exeltis, Merck Serono, Bayer, Teva, Theramex and Novartis, Astropharm, Ferring. The other authors had nothing to disclose. DISCLAIMER This Good Practice Recommendations (GPR) document represents the views of ESHRE, which are the result of consensus between the relevant ESHRE stakeholders and are based on the scientific evidence available at the time of preparation. ESHRE GPRs should be used for information and educational purposes. They should not be interpreted as setting a standard of care or be deemed inclusive of all proper methods of care, or be exclusive of other methods of care reasonably directed to obtaining the same results. They do not replace the need for application of clinical judgement to each individual presentation, or variations based on locality and facility type. Furthermore, ESHRE GPRs do not constitute or imply the endorsement, or favouring, of any of the included technologies by ESHRE." @default.
• W4380768002 created "2023-06-16" @default.
• W4380768002 creator A5000957083 @default.
• W4380768002 creator A5023368779 @default.
• W4380768002 creator A5027116242 @default.
• W4380768002 creator A5027671578 @default.
• W4380768002 creator A5031548295 @default.
• W4380768002 creator A5036821496 @default.
• W4380768002 creator A5040381425 @default.
• W4380768002 creator A5045978938 @default.
• W4380768002 creator A5071662033 @default.
• W4380768002 creator A5079813676 @default.
• W4380768002 date "2023-01-01" @default.
• W4380768002 modified "2023-10-09" @default.
• W4380768002 title "ESHRE good practice recommendations on recurrent implantation failure" @default.
• W4380768002 cites W1168175454 @default.
• W4380768002 cites W143645496 @default.
• W4380768002 cites W1562308323 @default.
• W4380768002 cites W1704243058 @default.
• W4380768002 cites W1909241615 @default.
• W4380768002 cites W1964370064 @default.
• W4380768002 cites W1966863746 @default.
• W4380768002 cites W1970309516 @default.
• W4380768002 cites W1973156525 @default.
• W4380768002 cites W1973908782 @default.
• W4380768002 cites W1974757833 @default.
• W4380768002 cites W1975517775 @default.
• W4380768002 cites W1989840489 @default.
• W4380768002 cites W1990480380 @default.
• W4380768002 cites W1996280689 @default.
• W4380768002 cites W2014555122 @default.
• W4380768002 cites W2014577065 @default.
• W4380768002 cites W2017057381 @default.
• W4380768002 cites W2018759861 @default.
• W4380768002 cites W2023916561 @default.
• W4380768002 cites W2031528961 @default.
• W4380768002 cites W2032787666 @default.
• W4380768002 cites W2042934567 @default.
• W4380768002 cites W2044630232 @default.
• W4380768002 cites W2050770555 @default.
• W4380768002 cites W2051882305 @default.
• W4380768002 cites W2054330426 @default.
• W4380768002 cites W2058789830 @default.
• W4380768002 cites W2066764528 @default.
• W4380768002 cites W2067960120 @default.
• W4380768002 cites W2068532217 @default.
• W4380768002 cites W2080059902 @default.
• W4380768002 cites W2095367047 @default.
• W4380768002 cites W2098067089 @default.
• W4380768002 cites W2100225664 @default.
• W4380768002 cites W2109952587 @default.
• W4380768002 cites W2113537324 @default.
• W4380768002 cites W2114725347 @default.
• W4380768002 cites W2115249034 @default.
• W4380768002 cites W2116695192 @default.
• W4380768002 cites W2116774269 @default.
• W4380768002 cites W2118346717 @default.
• W4380768002 cites W2126011537 @default.
• W4380768002 cites W2127153432 @default.
• W4380768002 cites W2127480283 @default.
• W4380768002 cites W2128717240 @default.
• W4380768002 cites W2128761082 @default.
• W4380768002 cites W2128769815 @default.
• W4380768002 cites W2129954469 @default.
• W4380768002 cites W2130126684 @default.
• W4380768002 cites W2131284669 @default.
• W4380768002 cites W2132362451 @default.
• W4380768002 cites W2140345134 @default.
• W4380768002 cites W2141003962 @default.
• W4380768002 cites W2144232514 @default.
• W4380768002 cites W2144338232 @default.
• W4380768002 cites W2145352608 @default.
• W4380768002 cites W2146213972 @default.
• W4380768002 cites W2146620291 @default.
• W4380768002 cites W2154419533 @default.
• W4380768002 cites W2157247344 @default.
• W4380768002 cites W2158265302 @default.
• W4380768002 cites W2162950674 @default.
• W4380768002 cites W2164130697 @default.
• W4380768002 cites W2165054515 @default.
• W4380768002 cites W2165965929 @default.
• W4380768002 cites W2167945936 @default.
• W4380768002 cites W2169342645 @default.
• W4380768002 cites W2171433675 @default.
• W4380768002 cites W2175923714 @default.
• W4380768002 cites W2207078070 @default.
• W4380768002 cites W2216659139 @default.
• W4380768002 cites W2223972615 @default.
• W4380768002 cites W2250383572 @default.
• W4380768002 cites W2279922973 @default.
• W4380768002 cites W2295733001 @default.
• W4380768002 cites W2338464139 @default.
• W4380768002 cites W2345078291 @default.
• W4380768002 cites W2345771897 @default.
• W4380768002 cites W2384442937 @default.
• W4380768002 cites W2400783197 @default.
• W4380768002 cites W2404947707 @default.
• W4380768002 cites W2417460230 @default.
• W4380768002 cites W2473943285 @default.
• W4380768002 cites W2515647003 @default.

• next